WO2001009373A3 - NATIVE Cdc25 SUBSTRATES, COMPOSITIONS AND USES RELATED THERETO - Google Patents
NATIVE Cdc25 SUBSTRATES, COMPOSITIONS AND USES RELATED THERETO Download PDFInfo
- Publication number
- WO2001009373A3 WO2001009373A3 PCT/US2000/020936 US0020936W WO0109373A3 WO 2001009373 A3 WO2001009373 A3 WO 2001009373A3 US 0020936 W US0020936 W US 0020936W WO 0109373 A3 WO0109373 A3 WO 0109373A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cdc25
- native
- substrates
- compositions
- uses related
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU63945/00A AU6394500A (en) | 1999-07-30 | 2000-07-31 | Native cdc25 substrates, compositions and uses related thereto |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36471599A | 1999-07-30 | 1999-07-30 | |
US09/364,715 | 1999-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001009373A2 WO2001009373A2 (en) | 2001-02-08 |
WO2001009373A3 true WO2001009373A3 (en) | 2001-10-11 |
Family
ID=23435750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/020936 WO2001009373A2 (en) | 1999-07-30 | 2000-07-31 | Native cdc25 substrates, compositions and uses related thereto |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6394500A (en) |
WO (1) | WO2001009373A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002239578A1 (en) * | 2000-11-07 | 2002-05-21 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as repreesented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Enhanced efficacy and safety of genotoxic therapy by p38 mapk modulation |
AU2003223926A1 (en) * | 2002-05-15 | 2003-12-02 | Lukas, Jiri | Modulation of mitosis by enhancing the interaction of cdc24a and cyclinb/cdk1 |
US7057052B2 (en) | 2002-09-26 | 2006-06-06 | Duke University | Heterocyclic quinones as pharmaceutical agents |
EP2255192A1 (en) * | 2008-03-26 | 2010-12-01 | Merck Patent GmbH | Method of long term storage of substrate-coupled beads |
CN102998450B (en) * | 2012-11-22 | 2014-10-15 | 北京正旦国际科技有限责任公司 | Immuno-mass spectrometric detection kit for esophagus cancer |
CA2937104A1 (en) * | 2014-01-16 | 2015-07-23 | Rowan University | Modulation of cellular localization of cyclin c |
CN110327463B (en) * | 2019-06-10 | 2021-11-16 | 西南民族大学 | Nano material containing gadolinium polytungstate and preparation method thereof |
CN110959851A (en) * | 2019-11-18 | 2020-04-07 | 青海晨菲制药有限公司 | Application of agaricus bisporus gallic acid in functional food |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010242A1 (en) * | 1991-11-18 | 1993-05-27 | Cold Spring Harbor Laboratory | NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
US5443962A (en) * | 1993-06-04 | 1995-08-22 | Mitotix, Inc. | Methods of identifying inhibitors of cdc25 phosphatase |
-
2000
- 2000-07-31 AU AU63945/00A patent/AU6394500A/en not_active Abandoned
- 2000-07-31 WO PCT/US2000/020936 patent/WO2001009373A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010242A1 (en) * | 1991-11-18 | 1993-05-27 | Cold Spring Harbor Laboratory | NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
US5443962A (en) * | 1993-06-04 | 1995-08-22 | Mitotix, Inc. | Methods of identifying inhibitors of cdc25 phosphatase |
Non-Patent Citations (5)
Title |
---|
BARATTE B ET AL: "SCREENING FOR ANTIMITOTIC COMPOUNDS USING THE CDC25 TYROSINE PHOSPHATASE, AN ACTIVATOR OF THE MITOSIS-INDUCING P34CDC2/CYCLIN BCDC13 PROTEIN KINASE", ANTICANCER RESEARCH,GR,HELENIC ANTICANCER INSTITUTE, ATHENS,, vol. 12, 1992, pages 873 - 880, XP002069498, ISSN: 0250-7005 * |
BORGNE A. & MEIJER L.: "Sequential dephosphorylation of p34cdc2 on Thr-14 and Tyr-15 at the prohase/metaphase transition", J. BIOLOG. CHEMISTRY, vol. 271, no. 44, - 1996, pages 27847 - 27854, XP002162637 * |
CLARK J.M. & GABRIELLI B.G.: "Production of a soluble cyclin B/cdc2 substrate for cdc25 phosphatase", ANALYT. CHEMISTRY, vol. 254, - 1997, pages 231 - 235, XP002162636 * |
MUELLER P R ET AL: "MYT1: A MEMBRANE-ASSOCIATED INHIBITORY KINASE THAT PHOSPHORYLATES CDC2 ON BOTH THREONINE-14 AND TYROSINE-15", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 270, 6 October 1995 (1995-10-06), pages 86 - 90, XP002057980, ISSN: 0036-8075 * |
STRAUSFELD U. ET AL.,: "Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein", NATURE, vol. 351, - 16 May 1991 (1991-05-16), pages 242 - 245, XP000942238 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001009373A2 (en) | 2001-02-08 |
AU6394500A (en) | 2001-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021281L (en) | Wash off investment composition | |
CA2281562A1 (en) | Forskolin for promoting lean body mass | |
WO2000053758A3 (en) | Compositions and methods for the treatment of immune related diseases | |
WO2002038190A3 (en) | Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates | |
WO2004094588A3 (en) | Postnatal stem cells and uses thereof | |
HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
WO2004069152A3 (en) | Δ4,5 glycuronidase and uses thereof | |
NZ504432A (en) | Use of lysophosphatidylethanolamine (18:1) and lysophosphatidylinositol to retard senescene and to enhance fruit ripening | |
AU2268301A (en) | Novel urea compounds, compositions and methods of use and preparation | |
WO2000066104A3 (en) | Ace-2 inhibiting compounds and methods of use thereof | |
WO2000073452A3 (en) | Compositions and methods for the treatment of immune related diseases | |
AU4549499A (en) | Polyurea-based adhesives, articles therefrom, and methods of their preparation and use | |
IE880732L (en) | Skin care composition | |
EP1568729A4 (en) | Polysiloxane having phosphorylcholine group and process for producing the same | |
MXPA05010384A (en) | Tacky skin care compositions and articles having tacky skin care compositions disposed thereon. | |
WO2001009373A3 (en) | NATIVE Cdc25 SUBSTRATES, COMPOSITIONS AND USES RELATED THERETO | |
WO2002092040A3 (en) | Topical product with visual indicator | |
HUP0101899A3 (en) | Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes, pharmaceutical compositions comprising thereof and their use | |
WO2002074924A3 (en) | Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof | |
MY152878A (en) | Novel cosmetic cream composition comprising c12-c20 fatty acid | |
HUP0104486A2 (en) | Tissue paper product, and process for making the product | |
GB9708278D0 (en) | Composition | |
AU2001283199A1 (en) | Methods and compositions for the diagnosis and treatment of brown adipose cell disorders | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU3819400A (en) | Adhesive system for silicones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |